Peter Hofland
Peter Hofland is the Executive Editor of ADC Review/Journal of Antibody-drug Conjugates, a comprehensive digital platform and peer reviewed publication focusing on news and information about innovative therapies such as Antibody-drug Conjugates (ADCs). Hofland contributes articles on the advances in ADCs - from initial discovery to approved drug. He is also the executive editor of Onco'Zine and a co-host of The Onco'Zine Brief, a radio/podcast show made for public radio.
